Search

The Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial demonstrated that the watch-and-wait strategy is safe for patients with stage 2 and stage 3 rectal cancers that achieve a clinical complete response (CCR) or near-complete clinical response (NCR) to total neoadjuvant therapy (TNT).

… Tuesday, February 13, 2024 The Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial demonstrated that the watch-and-wait strategy is safe for patients with stage 2 and stage 3 rectal cancers that achieve a clinical complete response (CCR) or near-complete clinical response (NCR) to

MSK researchers have identified a compound that kills glioblastoma cells using a mechanism that’s completely different from earlier treatments.

… Wednesday, March 6, 2019 Summary Using genetically engineered mouse models and high-throughput screening technologies, MSK researchers have found a surprising new approach for targeting glioblastoma. It involves focusing in on cancer stem cells. The type of brain tumor known as glioblastoma (GBM) is

Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence.

… Tuesday, August 29, 2017 Gerstner Sloan Kettering (GSK) Graduate School student stipends are supported by a variety of sources including philanthropic fellowships. Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence. Grayer Fellows Third-year

Kathryn was honored with The Leon J. Warshaw Leadership in Healthcare Award.

… Wednesday, December 15, 2021 Kathryn Martin , Chief Operating Officer of Memorial Sloan Kettering Cancer Center, was selected to receive this year’s The Leon J. Warshaw Leadership in Healthcare Award from the Northeast Business Group on Health (NEGBH). The award celebrates extraordinary service, leadership

Emerging evidence shows that immediate autologous breast reconstruction can tolerate radiotherapy better than previously thought in select cases.

… Wednesday, April 18, 2018 Emerging evidence shows that immediate autologous breast reconstruction can tolerate radiotherapy better than previously thought in select cases. Radiation can have major deleterious effects on the cosmetic outcomes of reconstructive procedures.  (1) As a result, the timing

Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.

… Monday, October 4, 2021 At first, Mikaela Rix was not worried about the tiny lump in her breast. It felt like a frozen pea, and she assumed it was a benign cyst. A former Boston College lacrosse player, 26-year-old Mikaela assumed she was in perfect health. She became uneasy when the radiologist looked

In 2024, Fred’s Team runners and donors brought in $8,529,723 to accelerate life-changing cancer research at Memorial Sloan Kettering Cancer Center.

… Friday, January 17, 2025 Fred’s Team, the official running program of Memorial Sloan Kettering Cancer Center (MSK), proudly announces another record-breaking year of fundraising in support of MSK’s mission of ending cancer for life. In 2024, Fred’s Team runners and donors raised $8,529,723 to accelerate

Memorial Sloan Kettering’s 41st annual ceremony recognized graduates and award winners with an online event.

… Friday, May 29, 2020 Summary Nobel Laureate James Allison addressed the eight graduates of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences with an online commencement address. Memorial Sloan Kettering’s 41st annual Academic Convocation and Commencement ceremony, held on May 27, looked

Learn more about the Neurology Multidisciplinary Care Clinic, which aims to help people with brain cancer and offer hope for their families.

… Friday, October 12, 2018 Gayle Rawlins-Peters and Anastasia Zankowsky Gayle Rawlins-Peters (left), a member of the case management team, and clinical social worker Anastasia Zankowsky are part of the Multidisciplinary Care Clinic. MSK neurologist Elena Pentsova Neurologist Elena Pentsova is co-director

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

… Monday, January 22, 2018 Summary Soft tissue sarcoma , a diverse group of cancers that arise in the body’s connective tissue, is difficult to treat after it has spread. MSK clinicians are investigating the use of immunotherapy to treat this disease. The main approaches involve checkpoint inhibitors and